BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 10810786)

  • 1. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification].
    Klingenheben T; Credner S; Li YG; Bender B; Hohnloser SH
    Z Kardiol; 2000; 89 Suppl 3():57-61. PubMed ID: 10810786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
    Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA
    Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy.
    Chauhan VS; Selvaraj RJ
    Curr Opin Cardiol; 2007 Jan; 22(1):25-32. PubMed ID: 17143041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study.
    Ikeda T; Yoshino H; Sugi K; Tanno K; Shimizu H; Watanabe J; Kasamaki Y; Yoshida A; Kato T
    J Am Coll Cardiol; 2006 Dec; 48(11):2268-74. PubMed ID: 17161258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
    Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG;
    J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
    Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
    Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W; Christ M; Bach J; Müller HH; Maisch B
    Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk stratification for sudden cardiac death: from the electrophysiological study to T-wave alternans].
    Pedretti RF; Sarzi Braga S; Vaninetti R; Laporta A; Masnaghetti S; Raimondo R; Rubin D; Santoro F; Salerno M
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):33S-39S. PubMed ID: 19195304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvolt T-wave alternans: a review of techniques, interpretation, utility, clinical studies, and future perspectives.
    Haghjoo M; Arya A; Sadr-Ameli MA
    Int J Cardiol; 2006 May; 109(3):293-306. PubMed ID: 16054250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
    Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
    Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined prognostic value of peak O(2) uptake and microvolt level T-wave alternans in patients with idiopathic dilated cardiomyopathy.
    Baravelli M; Fantoni C; Rogiani S; Farina S; Anzà C; Caltabiano V; Forzani T; Salerno-Uriarte JA
    Int J Cardiol; 2007 Sep; 121(1):23-9. PubMed ID: 17188766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
    J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arrhythmia risk stratification in patients with heart failure: prognostic evaluation of arrhythmia risk].
    Lombardi F
    Ital Heart J Suppl; 2001 Dec; 2(12):1284-90. PubMed ID: 11838349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microvolt T wave alternans as a predictor for sudden cardiac death].
    Tanno K; Katagiri T
    Nihon Rinsho; 2002 Jul; 60(7):1324-33. PubMed ID: 12136610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease.
    Rashba EJ; Osman AF; Macmurdy K; Kirk MM; Sarang SE; Peters RW; Shorofsky SR; Gold MR
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):170-6. PubMed ID: 15028046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T wave alternans for ventricular arrhythmia risk stratification.
    Sturdivant JL; Gold MR
    Minerva Cardioangiol; 2003 Feb; 51(1):15-9. PubMed ID: 12652256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive power of T-wave alternans and of ventricular gradient hysteresis for the occurrence of ventricular arrhythmias in primary prevention cardioverter-defibrillator patients.
    Man S; De Winter PV; Maan AC; Thijssen J; Borleffs CJ; van Meerwijk WP; Bootsma M; van Erven L; van der Wall EE; Schalij MJ; Burattini L; Burattini R; Swenne CA
    J Electrocardiol; 2011; 44(4):453-9. PubMed ID: 21704222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvolt T-wave alternans for the risk stratification of dangerous ventricular arrhythmias in patients with previously implanted automatic cardioverter-defibrillator.
    Lewandowski M; Kossuth I; Zielonka J; Wielusiński M; Kazimierczak A; Kornacewicz Jach Z; Przybycień K; Kaliszczak R
    Kardiol Pol; 2011; 69(6):580-5. PubMed ID: 21678296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.